Exact Mass: 365.1699108

Exact Mass Matches: 365.1699108

Found 19 metabolites which its exact mass value is equals to given mass value 365.1699108, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Isopentenyladenine-9-N-glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

C16H23N5O5 (365.1699108)


Isopentenyladenine-9-N-glucoside belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Isopentenyladenine-9-N-glucoside is a strong basic compound (based on its pKa). Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. [HMDB]

   

N6-isopentenyladenine-9-glucoside (iP9G)

N6-isopentenyladenine-9-glucoside (iP9G)

C16H23N5O5 (365.1699108)


   

N6-isopentenyladenine-7-glucoside (iP7G)

N6-isopentenyladenine-7-glucoside (iP7G)

C16H23N5O5 (365.1699108)


   

Antibiotic KF 77AG6|B,HCl-Antibiotic KF 77AG6

Antibiotic KF 77AG6|B,HCl-Antibiotic KF 77AG6

C16H23N5O5 (365.1699108)


   

1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine

1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine

C16H23N5O5 (365.1699108)


   

Isopentenyl-Adenine-9-glucoside

Isopentenyl-Adenine-9-glucoside

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyl-Adenine-7-glucoside

Isopentenyl-Adenine-7-glucoside

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

isopentenyl-Adenine-7-glucoside-[d6]

isopentenyl-Adenine-7-glucoside-[d6]

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

isopentenyl-Adenine-9-glucoside-[d6]

isopentenyl-Adenine-9-glucoside-[d6]

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

N6-Isopentenyladenine-7-glucoside

N6-Isopentenyladenine-7-glucoside

C16H23N5O5 (365.1699108)


   

N6-Isopentenyladenine-9-glucoside

N6-Isopentenyladenine-9-glucoside

C16H23N5O5 (365.1699108)


   
   
   

Isopentenyladenine-9-N-glucoside

Isopentenyladenine-9-N-glucoside

C16H23N5O5 (365.1699108)


   

7-(alpha-D-glucosyl)-N(6)-isopentenyladenine

7-(alpha-D-glucosyl)-N(6)-isopentenyladenine

C16H23N5O5 (365.1699108)


A glucosyl-N(6)-isopentenyladenine in which the glucosyl moiety is in the pyranose form, has alpha-D-configuration and is located at position N-7.

   

(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

C16H23N5O5 (365.1699108)


   

(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol

(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol

C16H23N5O5 (365.1699108)


   

(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5 (365.1699108)


   

2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5 (365.1699108)